DNER and glioblastoma: Similarly, BET blockade increases radiosensitivity in glioma and lung cancer by promoting DNA damage and G2/M checkpoint arrest (175), while in glioblastoma it suppresses super-enhancer-driven COL1A1, impairing DNA repair and enhancing tumor cell death (176).